The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias.
Paolillo R, Boulanger M, Gâtel P, Gabellier L, De Toledo M, Tempé D, Hallal R, Akl D, Moreaux J, Baik H, Gueret E, Recher C, Sarry JE, Cartron G, Piechaczyk M, Bossis G.
Paolillo R, et al. Among authors: bossis g.
Haematologica. 2022 Nov 1;107(11):2562-2575. doi: 10.3324/haematol.2021.279889.
Haematologica. 2022.
PMID: 35172562
Free PMC article.